Subgroup and meta-regression analyses within this meta-analysis demonstrated that the differences in PTX-3 levels between COPD patients and healthy controls, as well as between AECOPD and stable COPD patients, are consistent across various demographic and clinical characteristics. Here, PTX3 is linked to chronic obstructive pulmonary disease.